当前位置:
X-MOL 学术
›
Cancer Discov.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Structure of CD20 Bound to Rituximab Reveals Mechanistic Information.
Cancer Discovery ( IF 28.2 ) Pub Date : 2020-04-01 , DOI: 10.1158/2159-8290.cd-rw2020-031 American Association for Cancer Research
Cancer Discovery ( IF 28.2 ) Pub Date : 2020-04-01 , DOI: 10.1158/2159-8290.cd-rw2020-031 American Association for Cancer Research
The structure of CD20 with the antibody drug rituximab showed the binding mode and 2:2 stoichiometry.
中文翻译:
绑定到利妥昔单抗的CD20的结构揭示了机理信息。
具有抗体药物利妥昔单抗的CD20的结构显示了结合模式和2:2化学计量。
更新日期:2020-04-01
中文翻译:
绑定到利妥昔单抗的CD20的结构揭示了机理信息。
具有抗体药物利妥昔单抗的CD20的结构显示了结合模式和2:2化学计量。